LLY
784.63
+2.44%↑
UNH
532.21
+0.65%↑
JNJ
146.75
+0.14%↑
ABBV
169.97
-0.25%↓
NVO
87.95
+8.13%↑
LLY
784.63
+2.44%↑
UNH
532.21
+0.65%↑
JNJ
146.75
+0.14%↑
ABBV
169.97
-0.25%↓
NVO
87.95
+8.13%↑
LLY
784.63
+2.44%↑
UNH
532.21
+0.65%↑
JNJ
146.75
+0.14%↑
ABBV
169.97
-0.25%↓
NVO
87.95
+8.13%↑
LLY
784.63
+2.44%↑
UNH
532.21
+0.65%↑
JNJ
146.75
+0.14%↑
ABBV
169.97
-0.25%↓
NVO
87.95
+8.13%↑
LLY
784.63
+2.44%↑
UNH
532.21
+0.65%↑
JNJ
146.75
+0.14%↑
ABBV
169.97
-0.25%↓
NVO
87.95
+8.13%↑
24h
Actual
Mínimo
34.47
Máximo
34.91
Recomendaciones | Compra Fuerte |
---|---|
Estimación a 12 meses | +222.9 upside |
Próximas Ganancias | 5 feb 2025 |
---|
By Acuity
50%
50%
145 / 392 Clasificación en Healthcare
By Trading Central
Confianza
Bullish Evidence
32.51 / 34.86 Soporte y Resistencia
El rendimiento pasado no es un indicador fiable de resultados futuros.
23 dic 2024, 15:04 UTC
Eli Lilly, Novo Nordisk Stocks Rise. One of These Obesity Drugmakers Just Hit a Landmark. -- Barrons.com
DJ
Leer
13 dic 2024, 14:53 UTC
Ozempic Works on Kidney Disease, Regulator Says. Why Novo Nordisk Stock Is Falling. -- Barrons.com
DJ
Leer
4 nov 2024, 12:22 UTC
Viking Therapeutics Jumps On Latest Obesity Drug Data -- IBD
DJ
Leer
4 nov 2024, 12:00 UTC
Big Pharma's Obesity Bonanza Faces New Tests -- Heard on the Street -- WSJ
DJ
Leer
4 nov 2024, 10:11 UTC
Stock to Watch Monday: Trump Media, Viking Therapeutics, Nvidia, Intel -- WSJ
DJ
Leer
4 oct 2024, 12:01 UTC
As Weight-Loss Drugs Battle, Upstart Viking -2-
DJ
Leer
4 oct 2024, 12:01 UTC
As Weight-Loss Drugs Battle, Upstart Viking Therapeutics Threatens Eli Lilly, Novo Nordisk, Pfizer -- IBD
DJ
Leer
20 sept 2024, 13:55 UTC
Update: Novo's Wegovy Gets Backing of a Regulator for Heart Condition Treatment. FDA Could Be Next. -- Barrons.com
DJ
Leer
25 jul 2024, 15:03 UTC
Viking Stock Jumps After Company Speeds Development Its Weight-Loss Pill -- Barrons.com
DJ
Leer
1 mar 2024, 17:11 UTC
Stock Market Rally At Highs After Big Earnings, -2-
DJ
Leer
1 mar 2024, 17:11 UTC
Stock Market Rally At Highs After Big Earnings, Inflation Data: Weekly Review -- IBD
DJ
Leer
Cambio de precio
By TipRanks
Estimación a 12 meses
Media 111.4 USD 222.9%
Máximo 164 USD
Mínimo 74 USD
De acuerdo con 12 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Viking Therapeutics Inc Dist en los últimos 3 meses.
By TipRanks
Compra Fuerte
12 ratings
12
Comprar
0
Mantener
0
Vender
De acuerdo con 12 analistas que ofrecen calificaciones bursátiles a para Viking Therapeutics Inc Dist en los últimos 3 meses.
By Trading Central
Corto Plazo
Bullish Evidence
Recent bullish events outweigh bearish events.
Medio plazo
Strong Bearish Evidence
All events are bearish.
Largo Plazo
Strong Bearish Evidence
Recent bearish events outweigh bullish events.
By Acuity
Noticias sobre sentimiento de mercado
Neutral
Volatilidad
Por debajo de la media
Volumen de Noticias (RCV)
Por debajo de la media
$